| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Dale GL | |
| P2860 | cites work | Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen | Q41975625 |
| P433 | issue | 10 | |
| P304 | page(s) | 2185-2192 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | Coated-platelets: an emerging component of the procoagulant response | |
| P478 | volume | 3 |
| Q38777025 | A Comparison of Diffusion-Weighted Imaging Abnormalities Following Balloon Remodeling for Aneurysm Coil Embolization in the Ruptured vs Unruptured Setting |
| Q40491758 | A TMEM16F point mutation causes an absence of canine platelet TMEM16F and ineffective activation and death-induced phospholipid scrambling |
| Q33396138 | A colorimetric, metabolic dye reduction assay detects highly activated platelets: application in the diagnosis of heparin-induced thrombocytopenia |
| Q28543697 | A human platelet calcium calculator trained by pairwise agonist scanning |
| Q37205659 | A serotonin-induced N-glycan switch regulates platelet aggregation |
| Q35642785 | Active tissue factor pathway inhibitor is expressed on the surface of coated platelets |
| Q41278216 | Acute hemorrhagic complications are associated with lower coated-platelet levels in non-lacunar brain infarction |
| Q34209358 | Agonist-induced platelet procoagulant activity requires shear and a Rac1-dependent signaling mechanism. |
| Q33627153 | Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival. |
| Q36535484 | Alzheimer disease and platelets: how's that relevant |
| Q57823620 | Analysis of procoagulant phosphatidylserine-exposing platelets by imaging flow cytometry |
| Q50118987 | Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis. |
| Q28195907 | Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trial |
| Q37716126 | Association between Coagulation Function and Cerebral Microbleeds in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease |
| Q42002912 | Aβ Peptide Originated from Platelets Promises New Strategy in Anti-Alzheimer's Drug Development. |
| Q34906975 | Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention |
| Q46363763 | Cangrelor attenuates coated-platelet formation |
| Q40329444 | Coated platelets and severe haemophilia A bleeding phenotype: Is there a connection? |
| Q37216285 | Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII. |
| Q47682950 | Coated-Platelet Trends Predict Short-Term Clinical OutcomeAfter Subarachnoid Hemorrhage |
| Q34555294 | Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease |
| Q48839618 | Coated-platelet levels are elevated in patients with transient ischemic attack |
| Q28221893 | Coated-platelet levels are influenced by smoking, aspirin, and selective serotonin reuptake inhibitors |
| Q37277223 | Coated-platelets in ischemic stroke - potential insight into the etiology of stroke subtypes |
| Q46817734 | Coated-platelets in ischemic stroke: differences between lacunar and cortical stroke |
| Q26861509 | Contribution of blood platelets to vascular pathology in Alzheimer's disease |
| Q36407225 | Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis |
| Q57591132 | Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis |
| Q38046968 | Diagnosis and treatment of platelet hyperactivity in relation to thrombosis in dogs and cats. |
| Q36832592 | Dual mechanism of integrin αIIbβ3 closure in procoagulant platelets |
| Q48185470 | Dynamics of calcium spiking, mitochondrial collapse and phosphatidylserine exposure in platelet subpopulations during activation. |
| Q34182611 | Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients |
| Q43709701 | Elevated coated-platelets in symptomatic large-artery stenosis patients are associated with early stroke recurrence |
| Q35762807 | Extracellular matrix proteins in hemostasis and thrombosis |
| Q41118234 | Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets |
| Q38032520 | Fibrinogen and altered hemostasis in Alzheimer's disease |
| Q26767273 | Focus on Extracellular Vesicles: Introducing the Next Small Big Thing |
| Q52620808 | Functional cyclophilin D moderates platelet adhesion, but enhances the lytic resistance of fibrin. |
| Q35023065 | Functional factor XIII-A is exposed on the stimulated platelet surface |
| Q37156517 | Genetic dissection of platelet function in health and disease using systems biology |
| Q44155888 | Higher coated-platelet levels are associated with chronic hypertension in patients with transient ischemic attack |
| Q36587083 | Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction |
| Q61404383 | Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity |
| Q42504672 | ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. |
| Q35962620 | Identification of different proaggregatory abilities of activated platelet subpopulations |
| Q44481597 | Identification of signal transduction pathways involved in the formation of platelet subpopulations upon activation |
| Q36374930 | Influence of cardiopulmonary bypass on the interaction of recombinant factor VIIa with activated platelets |
| Q34018025 | Isolation and characterization of platelet-derived extracellular vesicles |
| Q24305071 | Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow |
| Q36503568 | Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention |
| Q50979186 | Low-density platelet populations demonstrate low in vivo activity in sporadic Alzheimer disease. |
| Q37234121 | Mitochondrially mediated integrin αIIbβ3 protein inactivation limits thrombus growth |
| Q57292650 | Monocytes of Different Subsets in Complexes with Platelets in Patients with Myocardial Infarction |
| Q36407002 | Necrotic platelets provide a procoagulant surface during thrombosis |
| Q42064117 | Pairwise agonist scanning-flow cytometry (PAS-FC) measures inside-out signaling and patient-specific response to combinatorial platelet agonists |
| Q27325578 | Partially Defective Store Operated Calcium Entry and Hem(ITAM) Signaling in Platelets of Serotonin Transporter Deficient Mice |
| Q33842909 | Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserine. |
| Q45866902 | Phenotype of severe hemophilia A and plasma levels of risk factors for thrombosis. |
| Q35450594 | Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow |
| Q59384153 | Platelet abnormalities in nephrotic syndrome |
| Q37119307 | Platelet activation by low concentrations of intact oxidized LDL particles involves the PAF receptor |
| Q26858851 | Platelet biomarkers in Alzheimer's disease |
| Q38521771 | Platelet dysfunction in injured patients |
| Q37940636 | Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome |
| Q37071701 | Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses |
| Q34034485 | Platelet response to serotonin in patients with stable coronary heart disease |
| Q48181349 | Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol. |
| Q46328596 | Platelet systems biology using integrated genetic and proteomic platforms |
| Q33427182 | Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia |
| Q26820857 | Platelet-based coagulation: different populations, different functions |
| Q34500658 | Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? |
| Q45865116 | Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist |
| Q50701332 | Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. |
| Q90484536 | Procoagulant Phosphatidylserine-Exposing Platelets in vitro and in vivo |
| Q37226166 | Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates |
| Q35166026 | Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase |
| Q36372812 | Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis. |
| Q33395666 | Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets |
| Q37066268 | R93W mutation in Orai1 causes impaired calcium influx in platelets |
| Q51886736 | Rate of progression in Alzheimer's disease correlates with coated-platelet levels--a longitudinal study. |
| Q33883732 | Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets |
| Q53242931 | Retracted: Platelet storage lesion: current proteomics approach. |
| Q35141182 | Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease |
| Q42684671 | Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells |
| Q36664166 | Roles of transglutaminases in cardiac and vascular diseases |
| Q30481898 | Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation |
| Q37873891 | Serine and metalloprotease signaling through PAR1 in arterial thrombosis and vascular injury. |
| Q45961045 | Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake. |
| Q91866948 | Serotonylation: Serotonin Signaling and Epigenetics |
| Q28551236 | Serum Metabolomics Reveals Serotonin as a Predictor of Severe Dengue in the Early Phase of Dengue Fever |
| Q38052936 | Substrates of Factor XIII-A: roles in thrombosis and wound healing |
| Q48273511 | Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling. |
| Q43696479 | Tetraspanin CD9 is required for microparticle release from coated-platelets |
| Q34993925 | The expanded biology of serotonin |
| Q39303326 | Transglutaminase-mediated transamidation of serotonin, dopamine and noradrenaline to fibronectin: evidence for a general mechanism of monoaminylation. |
Search more.